InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Goodman Noah. Insider active across 2 companies, notably Kymera Therapeutics, Inc.. In total, 11 reports have been recorded. Breakdown: 0 buy · 7 sells. Total volume traded: €871k. History available since 8 April 2025. The latest transaction was disclosed on 14 April 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
Goodman Noah is Chief Business Officer at Kymera Therapeutics, Inc. The 11 filings on record, all within the sampled recent period from 2025-04-09 to 2026-06-25, show sales of EUR 870651 and no purchases.